March 7, 2018 / 6:28 AM / a year ago

Novartis, U.S. partner plan remote trials to boost participation

ZURICH, March 7 (Reuters) - Novartis said on Wednesday it plans up to 10 clinical trials over three years using a U.S. partner's mobile technology to help free patients from burdensome hospital trips as the Swiss drugmaker aims to boost study participation and cut costs.

Novartis will work with Science 37, a Playa Vista, California-based startup that provides technology including smart phone apps to patients, allowing video-based telemedicine visits rather than always requiring physical travel to clinics. (Reporting by John Miller; Editing by Michael Shields)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below